Organization: Health Canada
Year: 2023
Month: October
Request Number: A-2023-000302
Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) inspection of the Bausch & Lomb facility in Rochester, New York, United States of America starting around 6 December 2022. Reference Number 502442.
Disposition: Disclosed in part
Number of pages: 39